great work

this leaves me with a question....yet to be answered

We believe the dose for efficacy in humans to be about 100mg/m2 to 200mg/m2. It is important to note that in the next phases it could be determined if it is best to dose twice a week. We are now dosing 50 and could achieve 100 in the next cohort. 

Source - Read More: http://investorshangout.com/post/794222/Got-a...z2WiNCMinX

Will EFFICACY be PR when observed or hoarded for publication in a Journal first?